Clinical Research Directory
Browse clinical research sites, groups, and studies.
iStent Inject New Enrollment Post-Approval Study
Sponsor: Glaukos Corporation
Summary
Study to evaluate the rate of clinically relevant complications associated with iStent inject placement in the post-market setting.
Official title: iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
358
Start Date
2020-09-22
Completion Date
2026-05
Last Updated
2024-02-23
Healthy Volunteers
No
Conditions
Interventions
iStent Inject Implantation
Subjects will be implanted with the iStent Injection Micro-Bypass device
Locations (3)
Eye Doctors of Arizona, PLLC
Phoenix, Arizona, United States
Wolstan and Goldberg Eye Associates
Torrance, California, United States
Glaucoma Associates of Texas
Dallas, Texas, United States